Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07332793
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 18 years or older
* Admission to the intensive care unit (ICU)
* Diagnosis of severe infection, including sepsis, based on established clinical criteria
* Enrollment within the early phase of ICU admission
* Informed consent obtained from the patient or a legally authorized representative
Exclusion Criteria:
* Age younger than 18 years
* Pregnancy or breastfeeding
* Known history of hematologic malignancy or active solid malignancy receiving chemotherapy
* Known primary immunodeficiency or long-term immunosuppressive therapy prior to ICU admission
* Human immunodeficiency virus (HIV) infection with severe immunosuppression
* Previous enrollment in this study
* Refusal or inability to provide informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07332793
Study Brief:
Protocol Section:
NCT07332793